Clinical Trials in Michigan

Showing 5601-5620 of 16,154 trials

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

NCT04913272

The aim of this Phase 2 study is to evaluate the safety and efficacy of the live biotherapeutic product, KT-301 (formerly US-APR2020), in the management of patients with CKD Stage IV.

Chronic Kidney Disease stage4

Kibow Pharma630 participantsStarted Jun 2021

Silver Spring, Maryland, United States • Saginaw, Michigan, United States • Orangeburg, South Carolina, United States +2 more locations

TERMINATEDPhase 237 miles

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

NCT05655299

This is a study to understand if taking VTX958 is safe and effective in participants diagnosed with moderate to severe psoriasis (PsO). Approximately 200 patients will take VTX958 Dose A, VTX958 Dose B, VTX958 Dose C, VTX958 Dose D, or placebo. The study consists of a 30-day Screening Period (to see if a participant qualifies for the study), a 16-week double-blind period (a participant receives active Dose A, Dose B, Dose C, Dose D, or placebo), a 16-week Long Term Extension (LTE) period, a 36-week Open Label Extension (OLE) period and a 4-week Follow-Up Period. The maximal duration of treatment will be approximately 16 months.

Psoriasis

Ventyx Biosciences, Inc222 participantsStarted Nov 2022

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +60 more locations

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Find Trials by Condition in Michigan

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Clinical Evaluation of the i-STAT TBI Test

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Breast Cancer Index (BCI) Registry

IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer

Systane® Hydration PF and Systane® Hydration Preserved

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Strategies to Assist With Management of Pain

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Voice Adaptive Tablet-Based Naming Treatment for Adults With Aphasia

Health Outcomes of Parents With Cystic Fibrosis

Air Optix® Night and Day® Aqua Continuous Wear

Umbilical Cord Milking in Non-Vigorous Infants

Acupuncture for Preterm Infants Requiring Eye-exam